Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
252.5500 5.50 (2.23%)
NSE Jun 27, 2025 15:31 PM
Volume: 936.2K
 

252.55
2.23%
Karvy
The company reported revenue growth of 8.9% for Q4FY15 over Q4FY14 and annual revenue reported a growth of 26.4% for FY15 over FY14.The company's Europe & UK segment reported growth of 25.7% while the US & North America reported growth of 65.3%. The improved product mix is reflected in operating margins which to 23.2% from 19.2% in FY14
Marksans Pharma Ltd. has gained 58.75% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended